Advertisement
Screener

PERSPECTIVE THERAPEUTICS, INC. (CATX) Form D

PERSPECTIVE THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-03-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-03-04; Total offering amount $87,409,482.
  • 2024-01-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-01-08; Total offering amount $20,846,671.
  • 2023-02-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2023-02-03; Total offering amount $54,618,030.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-03-18Rule 506(b)Equity2024-03-04$87,409,482$87,409,482$09
2024-01-22Rule 506(b)Equity2024-01-08$20,846,671$20,846,671$01
2023-02-21Rule 506(b)Equity2023-02-03$54,618,030$54,618,030$054

Similar stocks

Stock NameCountryMarket CapPE Ratio
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58